109 research outputs found

    The influence of breast cancer-related lymphedema on women's return-to-work

    Get PDF
    The majority of women who develop breast cancer are under retirement age. Therefore, occupational functioning and employment are issues of significant concern. Breast cancer-related lymphedema (BCRL) is one of the major treatment complications for breast cancer patients and it has been shown to be associated with adverse work outcomes. This study is one of the first to ask "how and why" lymphedema may interact with breast cancer survivors' return-to-work. The International Classification of Functioning, Disability, and Health (ICF), which was adopted to guide research design and analysis of data related to health outcomes, was used as a platform for thinking about the phenomenon of return-to-work. Case study methodologies drawn from Yin's (2014) definition were employed in this dissertation study. Thirteen women with BCRL were enrolled in this study. Participants completed a survey and then participated in a sixty-minute semi-structured individual interview. The results suggested that the return-to-work experience was shaped by interactions of the disease processes, the work activities required, the individual, and an array of environmental factors. Four main themes emerged: 1) BCRL affects physical and emotional functioning associated with work; 2) On-going treatment for BCRL creates challenges for work; 3) Environmental factors affect the work experience; and 4) Personal factors play a key role in adjusting to return-to-work. The findings shared considerable agreement with ICF model and suggested new perspectives towards understanding the model. This study suggests implications for BCRL education, clinical practice, health policy, and research.Includes bibliographical reference

    A Causal And-Or Graph Model for Visibility Fluent Reasoning in Tracking Interacting Objects

    Full text link
    Tracking humans that are interacting with the other subjects or environment remains unsolved in visual tracking, because the visibility of the human of interests in videos is unknown and might vary over time. In particular, it is still difficult for state-of-the-art human trackers to recover complete human trajectories in crowded scenes with frequent human interactions. In this work, we consider the visibility status of a subject as a fluent variable, whose change is mostly attributed to the subject's interaction with the surrounding, e.g., crossing behind another object, entering a building, or getting into a vehicle, etc. We introduce a Causal And-Or Graph (C-AOG) to represent the causal-effect relations between an object's visibility fluent and its activities, and develop a probabilistic graph model to jointly reason the visibility fluent change (e.g., from visible to invisible) and track humans in videos. We formulate this joint task as an iterative search of a feasible causal graph structure that enables fast search algorithm, e.g., dynamic programming method. We apply the proposed method on challenging video sequences to evaluate its capabilities of estimating visibility fluent changes of subjects and tracking subjects of interests over time. Results with comparisons demonstrate that our method outperforms the alternative trackers and can recover complete trajectories of humans in complicated scenarios with frequent human interactions.Comment: accepted by CVPR 201

    Effects of Quercetin on Uric Acid Metabolism

    Get PDF
    Background and Objective: High blood uric acid (hyperuricemia) is a common phenomenon in populations with hypertension, hyperglycemia, obesity and/or dyslipidemia. This study was to investigate the effects of quercetin supplementation on blood uric acid level and the biochemical mechanism behind it. Methods: A pilot trial confirmed the delivery of quercetin from a supplement tablet in healthy males (n=6). Randomised, double-blind, cross-over, placebo-controlled 4-week dietary intervention trial with the same supplement tablet containing 500 mg quercetin d-1 was conducted in selected healthy males (n=22, with higher blood uric acid but within normal range). Changes of uric acid and glucose were analysed in fasting blood plasma at 0, 2 and 4 weeks. Plasma metabolomics were profiled by 1H-NMR. Where quercetin and its metabolites may affect in the pathway of uric acid metabolism was investigated in vitro and ex vivo. Results: At the end of the 4-week trial, plasma uric acid levels were significantly reduced (mean change -26.5 µM, 95% CI -7.6 to -45.5, P = 0.008, n=22), as were diastolic blood pressures in normotensive subjects (-3.1 mm Hg, -0.5 to -5.8, P = 0.048, n=10). Paired plasma 1H-NMR spectrum showed lowered glutamine (P = 0.008), acetoacetate (P = 0.005) and lactate (P = 0.03) after quercetin treatment. A dose-dependent inhibition of quercetin, quercetin-3'-O-sulfate and 3,4-dihydroxyphenylacetic acid on xanthine oxidase in vitro and a mild inhibitory effect of quercetin on plasma adenosine deaminase was found. Conclusions: Quercetin supplementation can maintain blood uric acid level and blood pressure within a low-risk range. It is probably a result of regulated purine metabolism by quercetin, its microbial derivatives and their metabolites
    • …
    corecore